Research ArticleBasic Science Investigation
186Re-Etidronate in Breast Cancer Patients with Metastatic Bone Pain
Shiuw H. Han, Bernard A. Zonnenberg, John M.H. de Klerk, Jac M.S.P. Quirijnen, Alfred D. van het Schip, Aalt van Dijk, Geert H. Blijham and Peter P. van Rijk
Journal of Nuclear Medicine April 1999, 40 (4) 639-642;
Shiuw H. Han
Bernard A. Zonnenberg
John M.H. de Klerk
Jac M.S.P. Quirijnen
Alfred D. van het Schip
Aalt van Dijk
Geert H. Blijham
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
186Re-Etidronate in Breast Cancer Patients with Metastatic Bone Pain
Shiuw H. Han, Bernard A. Zonnenberg, John M.H. de Klerk, Jac M.S.P. Quirijnen, Alfred D. van het Schip, Aalt van Dijk, Geert H. Blijham, Peter P. van Rijk
Journal of Nuclear Medicine Apr 1999, 40 (4) 639-642;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Bone-Seeking Radionuclides For Therapy
- The Placorhen Study: A Double-Blind, Placebo-Controlled, Randomized Radionuclide Study with 186Re-Etidronate in Hormone-Resistant Prostate Cancer Patients with Painful Bone Metastases
- Therapy of Metastatic Bone Pain
- Skeletal Uptake and Soft-Tissue Retention of 186Re-HEDP and 153Sm-EDTMP in Patients with Metastatic Bone Disease
- Quantitative Bone Single-Photon Emission Computed Tomography for Prediction of Pain Relief in Metastatic Bone Disease Treated With Rhenium-186 Etidronate